Matthieu Leclerc-Chalvet Email & Phone Number

Nice, Provence-Alpes-Côte D'Azur, Fr

Therapixel develops an AI-based software to assist radiologists in the diagnosis of breast cancer. Our algorithm dedicated to screening won the Digital Mammography DREAM challenge organised by IBM, over 1,150 participants.

London, London, Gb

Leniomed is a start up created to provide the medical community world wide with innovative products that bring immediate clinical benefits and effectiveness.The first targeted market is the objective assessment of wounds. Leniomed provides an easy to use, accurate and reliable imaging tool that can be used by any health professional at the point of care.By taking a digital picture of a wound and processing it in real time with our software, ScanOSkin, healthcare professionals will l be able to either interpret the Augmented Reality image or sent it to a reference centre for expert advice (telemedicine). Visit www.scanoskin.com to learn more.

Oxford, Oxfordshire, Gb

Hired to structure the operations for scale-up, and grow EMEA business. Working with the board on growth plans, fund raising and potential exit. Raised £6m from Apposite Capital.Ended 3 years of flat revenue and return to double digit growth. Identified and hired key roles to increase efficiency of capital employed. Established a strategic partnership with BTG plc. Released the first commercial AI product for radiation oncology, using Deep Learning and SaaS deployment, and acquired the first paying users in EMEA within months of launching.

San Clemente, California, Us

Define and execute the global product strategy for the Airway franchise (£240m annual turnover), including organic and external growth opportunities, portfolio management and cost improvement with a team of 12.P&L responsibilty for the Assisted Reporduction global business unit, team of 13, double digit growth.Spearheaded a process for front end selection of new product ideas based on Real/Win/Worth criteria; rolled out in other franchises and divisions of Smiths.Lead the commercial due diligence for an acquisition in emerging markets.

P&L accountability for Commercial, Clinical Affairs, Corporate Marketing and IP.• Turned around the commercial strategies to speed up innovation adoption. Facing a slow uptake of a revolutionary regenerative technology, focused the limited resources on a smaller number of territories and indications to establish a solid customer base using distributors and direct resources. Year on year sales doubled to £500k. • Translated clinical results into customer value.Shaped the company’s clinical experience in regenerative medicine into documents supporting the unique selling proposition, working closely with the founder, Prof F. Wood and local reimbursement authorities. Gathering worldwide key opinion leaders and obtained their endorsement of the recommendations to use a cell therapy product for vitiligo.• Steered corporate strategy to preserve shareholder value, through regular Board update, triggered the strategic review in May’07 and made recommendations for restructuring: redeployment of resources on viable product, identification of licensees for cell culture and business partners for mid term exit.

Boston, Ma, Us

• Built commercial operations from scratch.Starting with a team of 6 sales representatives across Europe, developed a structured sales operation organisation of 32 people and a number of agents and distributors in 11 countries. This involved numerous hire as well as individual development plans, and establishing countries structure during the separation of Oncura from Amersham.• Penetrated multi-disciplinary market with minimally invasive innovations.The sales team grew a minimally invasive treatment for prostate cancer from 2 to 7% penetration; with sales growing from $3.8m to $26m (>50% CAGR).• Streamlined business processes for increased return on investment.To speed up treatment centre openings, equipment could be invested after approval of a business case; monitored closely the sales funnel ensured the ROI was delivered.

Business leadership for Home Care Respiratory products ($50m turnover).• Established European Marketing Management Team. Convinced managers in the countries to collaborate with the European organisation in order to have their voice heard at the corporate level, which improved global market knowledge and strategic planning.• Facilitated the emergence of a global product platform. As a member of the Global Product Team, orchestrated the adoption of a single set of features for a new range of sleep apnoea devices by all European countries. Coordinated marketing, R&D and production teams lead to globalize this platform and maintain European R&D and manufacturing.

Us

Executive Programme, General Management

Doctor Of Philosophy (Phd), Business, Marketing And Entreprise

Msc, Biomedical Engineering